Cardiopulmonary Consequences of Vaping in Adolescents
Published: June 21, 2022
- Although the FDA has not approved e-cigarettes as a tobacco cessation aid, industry has at times positioned their products in that way. Their use has increased significantly within the last decade, with new types of products entering the marketplace. Thus, more understanding of the respiratory and cardiovascular consequences of e-cigarettes is needed.
- These products are increasingly used by youth and young adults, but due to their more recent appearance on the market, long-term epidemiologic studies are not available. In addition, preclinical studies of e-cigarette effects on naïve organ systems have mainly used adult animals which makes translation of health effects to adolescents difficult.
- The goal of this scientific statement is to provide background on the cardiopulmonary consequences of e-cigarette use (vaping) in adolescents, and to guide therapeutic strategies and inform public policy makers on the short- and long-term risks of vaping.
Supporting Materials
Recommended Reading
- 2019 Guideline on the Primary Prevention of Cardiovascular Disease
- 2016 Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease
- Guidelines for the Primary Prevention of Stroke
- New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention
- Electronic Cigarettes
- Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond